Doc, I appreciate your giving clarity to this thing. I know you're beyond busy. I have a question and am hoping if you see this post you can shed a little light on it.
I'm reading where tPA has shown some promise in those with advanced COVID-19 by breaking up pulmonary clots and also small clots in the aveoli. Apparently COVID pts are hypercoagulable and are clotting off their IVs, as well as having kidney and heart failure. A 2001 study showed promise in this area and I believe there is a compassionate use study underway. As an ER doc, I assume you've had experience with lytics for MI and stroke. I know it's damned expensive, but nearly every ER should have it on hand. Any thoughts regarding tPA as advanced COVID therapy?
Thanks again.
cf
